EpiVacCorona
EpiVacCorona Uses, Dosage, Side Effects, Food Interaction and all others data.
EpiVacCorona Vaccine, developed by the Vektor State Research Center of Virology and Biotechnology in Russia, is based on peptide-antigens that facilitate immunity to the SARS-CoV-2 virus. It is currently being tested in Phase I/II clinical trials for safety and immunogenicity (NCT04527575).
Trade Name | EpiVacCorona |
Generic | EpiVacCorona |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here EpiVacCorona